

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.71797999 |
| 2 | adhesion of symbiont to host cell (GO:0044650) | 6.65462196 |
| 3 | virion attachment to host cell (GO:0019062) | 6.65462196 |
| 4 | vitamin A metabolic process (GO:0006776) | 6.63150611 |
| 5 | positive regulation of triglyceride lipase activity (GO:0061365) | 6.54998675 |
| 6 | positive regulation of lipoprotein lipase activity (GO:0051006) | 6.54998675 |
| 7 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.02781493 |
| 8 | adhesion of symbiont to host (GO:0044406) | 5.75496509 |
| 9 | phospholipid efflux (GO:0033700) | 5.19763874 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.19359007 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07954032 |
| 12 | digestive system process (GO:0022600) | 4.81765758 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 4.80132347 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.75576571 |
| 15 | cytidine metabolic process (GO:0046087) | 4.74894113 |
| 16 | cytidine catabolic process (GO:0006216) | 4.74894113 |
| 17 | cytidine deamination (GO:0009972) | 4.74894113 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.63722468 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 4.60670961 |
| 20 | plasma lipoprotein particle assembly (GO:0034377) | 4.57005795 |
| 21 | protein-lipid complex assembly (GO:0065005) | 4.48210539 |
| 22 | modified amino acid transport (GO:0072337) | 4.48177445 |
| 23 | actin filament depolymerization (GO:0030042) | 4.46733665 |
| 24 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.32872174 |
| 25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.14433944 |
| 26 | flavonoid metabolic process (GO:0009812) | 4.11043828 |
| 27 | peptide catabolic process (GO:0043171) | 4.10825661 |
| 28 | cholesterol efflux (GO:0033344) | 4.04176594 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 4.03582309 |
| 30 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91264786 |
| 31 | innate immune response in mucosa (GO:0002227) | 3.88367019 |
| 32 | lipoprotein metabolic process (GO:0042157) | 3.88361946 |
| 33 | hormone catabolic process (GO:0042447) | 3.86806382 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.85077875 |
| 35 | B cell mediated immunity (GO:0019724) | 3.85013787 |
| 36 | drug catabolic process (GO:0042737) | 3.81846318 |
| 37 | protein kinase C signaling (GO:0070528) | 3.81789664 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.78683032 |
| 39 | type I interferon signaling pathway (GO:0060337) | 3.78683032 |
| 40 | response to protozoan (GO:0001562) | 3.77365678 |
| 41 | response to peptidoglycan (GO:0032494) | 3.75602960 |
| 42 | response to type I interferon (GO:0034340) | 3.74484561 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.69864448 |
| 44 | transcytosis (GO:0045056) | 3.69776386 |
| 45 | defense response to protozoan (GO:0042832) | 3.68949103 |
| 46 | drinking behavior (GO:0042756) | 3.67659739 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.64769928 |
| 48 | regulation of chronic inflammatory response (GO:0002676) | 3.62752383 |
| 49 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.62226988 |
| 50 | response to hepatocyte growth factor (GO:0035728) | 3.61722581 |
| 51 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.61722581 |
| 52 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.58651197 |
| 53 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.57675175 |
| 54 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.57675175 |
| 55 | T cell migration (GO:0072678) | 3.50282234 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48861076 |
| 57 | phospholipid scrambling (GO:0017121) | 3.48556700 |
| 58 | glucose 6-phosphate metabolic process (GO:0051156) | 3.47209206 |
| 59 | regulation of vitamin metabolic process (GO:0030656) | 3.44787469 |
| 60 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.43354135 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.42969001 |
| 62 | diacylglycerol metabolic process (GO:0046339) | 3.42689962 |
| 63 | digestion (GO:0007586) | 3.39268450 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37029974 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36326804 |
| 66 | cholesterol homeostasis (GO:0042632) | 3.32310721 |
| 67 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.32246925 |
| 68 | sterol transport (GO:0015918) | 3.31189735 |
| 69 | cholesterol transport (GO:0030301) | 3.31189735 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30131953 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.29400086 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 3.29400086 |
| 73 | sulfation (GO:0051923) | 3.27936976 |
| 74 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.27146571 |
| 75 | response to hydroperoxide (GO:0033194) | 3.26657808 |
| 76 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.26288288 |
| 77 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.26175183 |
| 78 | sterol homeostasis (GO:0055092) | 3.25844963 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25535526 |
| 80 | peptide hormone processing (GO:0016486) | 3.23992456 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23865676 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23865676 |
| 83 | regulation of chemokine biosynthetic process (GO:0045073) | 3.23416190 |
| 84 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.22372097 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.20821026 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20164525 |
| 87 | positive thymic T cell selection (GO:0045059) | 3.17829803 |
| 88 | positive regulation of interferon-alpha production (GO:0032727) | 3.16944134 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.15916665 |
| 90 | thyroid hormone metabolic process (GO:0042403) | 3.15214866 |
| 91 | positive regulation of defense response to virus by host (GO:0002230) | 3.14884812 |
| 92 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.13969134 |
| 93 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.13945820 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 3.13937009 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 3.13924967 |
| 96 | mucosal immune response (GO:0002385) | 3.13135238 |
| 97 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.10508351 |
| 98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10028751 |
| 99 | negative regulation of viral genome replication (GO:0045071) | 3.09569886 |
| 100 | regulation of immunoglobulin secretion (GO:0051023) | 3.09282678 |
| 101 | negative T cell selection (GO:0043383) | 3.08565989 |
| 102 | response to interferon-beta (GO:0035456) | 3.07342754 |
| 103 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06765482 |
| 104 | hydrogen peroxide catabolic process (GO:0042744) | 3.04487953 |
| 105 | viral entry into host cell (GO:0046718) | 3.04080889 |
| 106 | cellular response to interferon-beta (GO:0035458) | 3.03653421 |
| 107 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.00244125 |
| 108 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99105766 |
| 109 | actin nucleation (GO:0045010) | 2.97759285 |
| 110 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.97756964 |
| 111 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.97231233 |
| 112 | hepatocyte apoptotic process (GO:0097284) | 2.96600271 |
| 113 | negative thymic T cell selection (GO:0045060) | 2.96596018 |
| 114 | sulfate transmembrane transport (GO:1902358) | 2.96379554 |
| 115 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.95772007 |
| 116 | regulation of lipoprotein metabolic process (GO:0050746) | 2.94847056 |
| 117 | regulation of interleukin-12 production (GO:0032655) | 2.94604413 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.93995817 |
| 119 | positive regulation of type 2 immune response (GO:0002830) | 2.93763956 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.93710571 |
| 121 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93265992 |
| 122 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.92776922 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.92639982 |
| 124 | lipoprotein transport (GO:0042953) | 2.92624574 |
| 125 | organ or tissue specific immune response (GO:0002251) | 2.91596145 |
| 126 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.90591462 |
| 127 | regulation of growth of symbiont in host (GO:0044126) | 2.90591462 |
| 128 | negative regulation of growth of symbiont in host (GO:0044130) | 2.90591462 |
| 129 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.90591462 |
| 130 | oligosaccharide catabolic process (GO:0009313) | 2.89507018 |
| 131 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86967431 |
| 132 | drug transport (GO:0015893) | 2.86082592 |
| 133 | regulation of digestive system process (GO:0044058) | 2.86010291 |
| 134 | positive T cell selection (GO:0043368) | 2.85195765 |
| 135 | response to muramyl dipeptide (GO:0032495) | 2.84893148 |
| 136 | negative regulation of digestive system process (GO:0060457) | 2.83792406 |
| 137 | positive regulation of interleukin-2 production (GO:0032743) | 2.83029438 |
| 138 | positive regulation of interferon-beta production (GO:0032728) | 2.82460374 |
| 139 | protein-lipid complex subunit organization (GO:0071825) | 2.80266716 |
| 140 | high-density lipoprotein particle remodeling (GO:0034375) | 2.80266396 |
| 141 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.78915741 |
| 142 | B cell receptor signaling pathway (GO:0050853) | 2.78314183 |
| 143 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78199144 |
| 144 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.77092062 |
| 145 | regulation of T-helper cell differentiation (GO:0045622) | 2.76420415 |
| 146 | cellular response to interferon-gamma (GO:0071346) | 2.76095519 |
| 147 | T-helper 1 type immune response (GO:0042088) | 2.75797234 |
| 148 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.75754857 |
| 149 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.74979961 |
| 150 | positive regulation of interleukin-10 production (GO:0032733) | 2.74205483 |
| 151 | NADH metabolic process (GO:0006734) | 2.73926699 |
| 152 | keratinization (GO:0031424) | 2.73758783 |
| 153 | plasma lipoprotein particle organization (GO:0071827) | 2.73536938 |
| 154 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.73375966 |
| 155 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72072488 |
| 156 | regulation of podosome assembly (GO:0071801) | 2.70914480 |
| 157 | * regulation of B cell apoptotic process (GO:0002902) | 2.69849549 |
| 158 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.69526873 |
| 159 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69239662 |
| 160 | leukocyte aggregation (GO:0070486) | 2.68963291 |
| 161 | positive regulation of isotype switching (GO:0045830) | 2.68678095 |
| 162 | positive regulation of interleukin-12 production (GO:0032735) | 2.67470521 |
| 163 | thrombin receptor signaling pathway (GO:0070493) | 2.66846463 |
| 164 | negative regulation of type I interferon production (GO:0032480) | 2.66829213 |
| 165 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.65645488 |
| 166 | ribosomal small subunit assembly (GO:0000028) | 2.65090857 |
| 167 | dendritic cell differentiation (GO:0097028) | 2.64067820 |
| 168 | positive regulation of heat generation (GO:0031652) | 2.63094445 |
| 169 | protein-lipid complex remodeling (GO:0034368) | 2.62894636 |
| 170 | macromolecular complex remodeling (GO:0034367) | 2.62894636 |
| 171 | plasma lipoprotein particle remodeling (GO:0034369) | 2.62894636 |
| 172 | regulation of actin nucleation (GO:0051125) | 2.62713374 |
| 173 | regulation of B cell differentiation (GO:0045577) | 2.61020822 |
| 174 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59391261 |
| 175 | sulfur compound transport (GO:0072348) | 2.59060102 |
| 176 | T cell selection (GO:0045058) | 2.59052176 |
| 177 | regulation of sterol transport (GO:0032371) | 2.58790171 |
| 178 | regulation of cholesterol transport (GO:0032374) | 2.58790171 |
| 179 | regulation of RIG-I signaling pathway (GO:0039535) | 2.57943952 |
| 180 | * positive regulation of B cell activation (GO:0050871) | 2.57735548 |
| 181 | folic acid transport (GO:0015884) | 2.57647284 |
| 182 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.57277733 |
| 183 | removal of superoxide radicals (GO:0019430) | 2.56846368 |
| 184 | cellular response to superoxide (GO:0071451) | 2.56846368 |
| 185 | cellular response to oxygen radical (GO:0071450) | 2.56846368 |
| 186 | positive regulation of granulocyte differentiation (GO:0030854) | 2.56388659 |
| 187 | sphingomyelin metabolic process (GO:0006684) | 2.56312022 |
| 188 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.56234713 |
| 189 | cellular response to exogenous dsRNA (GO:0071360) | 2.56149021 |
| 190 | macrophage activation involved in immune response (GO:0002281) | 2.56081781 |
| 191 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55429385 |
| 192 | modulation by symbiont of host defense response (GO:0052031) | 2.55429385 |
| 193 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55429385 |
| 194 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55429385 |
| 195 | modulation by symbiont of host immune response (GO:0052553) | 2.55429385 |
| 196 | sulfate transport (GO:0008272) | 2.54672103 |
| 197 | intestinal absorption (GO:0050892) | 11.3851043 |
| 198 | intestinal cholesterol absorption (GO:0030299) | 10.6038493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.32393126 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.81814082 |
| 3 | * TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.58826863 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.17429515 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.06736698 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.64024853 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.48195365 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.43042335 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38497095 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04799133 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95339858 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82498368 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.81960665 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.79914829 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79855187 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79162670 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77192032 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76953922 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.75406293 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.74542770 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.73324042 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73009736 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72463449 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.65884097 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.64397997 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64269757 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63868023 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61319972 |
| 29 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.60586151 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60480747 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59967529 |
| 32 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59603809 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58041484 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56341669 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55450434 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53372768 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51912685 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.51894930 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51598142 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50562970 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50195631 |
| 42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.50071527 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46498341 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44963991 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43584905 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42535286 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41252241 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40823627 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39603369 |
| 50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.39291491 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39271064 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37786961 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37130925 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36067459 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35363751 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34954129 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.34837117 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33713282 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31783883 |
| 60 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.30660555 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29409989 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28896653 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.28676481 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25405735 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24819368 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.23642566 |
| 67 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.23199393 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21869119 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21570820 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21506115 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20639454 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20609968 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.20269151 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20135783 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20071213 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19846957 |
| 77 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19408598 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19134448 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18810859 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17728204 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17715575 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17407567 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.17367177 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16887176 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16551751 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14874338 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14273540 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13660371 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13391005 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11991414 |
| 91 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11186405 |
| 92 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10693671 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10359334 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09504961 |
| 95 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08806095 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08000150 |
| 97 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07957878 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07650239 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07393273 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07290741 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06979559 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06970890 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06542220 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06283042 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05620021 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05595130 |
| 107 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05553611 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05356686 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04794146 |
| 110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04521636 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03551994 |
| 112 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02621598 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01449635 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01236876 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01228226 |
| 116 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00347818 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99762358 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99390381 |
| 119 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99307751 |
| 120 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99220336 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97325627 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97304212 |
| 123 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97215023 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96787923 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96652529 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96544772 |
| 127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96283611 |
| 128 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95947105 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95621486 |
| 130 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95469058 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95003077 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94180858 |
| 133 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.94159698 |
| 134 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93696156 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93308635 |
| 136 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93000144 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92007302 |
| 138 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91927715 |
| 139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91696226 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91635592 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91484299 |
| 142 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89034463 |
| 143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88854197 |
| 144 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86839667 |
| 145 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86839667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.27314110 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.25795526 |
| 3 | MP0003303_peritoneal_inflammation | 4.40017861 |
| 4 | MP0006054_spinal_hemorrhage | 4.01888285 |
| 5 | MP0009840_abnormal_foam_cell | 3.74201400 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.35853899 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.05751588 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.01390938 |
| 9 | MP0001790_abnormal_immune_system | 2.92404438 |
| 10 | MP0005387_immune_system_phenotype | 2.92404438 |
| 11 | MP0009278_abnormal_bone_marrow | 2.74695681 |
| 12 | MP0006082_CNS_inflammation | 2.66460439 |
| 13 | MP0003866_abnormal_defecation | 2.45149089 |
| 14 | MP0004147_increased_porphyrin_level | 2.37674542 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.36468622 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.28083441 |
| 17 | MP0009764_decreased_sensitivity_to | 2.22780121 |
| 18 | MP0000490_abnormal_crypts_of | 2.14805673 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.11855595 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.93391688 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.86615423 |
| 22 | MP0000462_abnormal_digestive_system | 1.85127218 |
| 23 | MP0001853_heart_inflammation | 1.84815971 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.78478297 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.72967299 |
| 26 | MP0004510_myositis | 1.72581465 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.71650498 |
| 28 | MP0001663_abnormal_digestive_system | 1.70889383 |
| 29 | MP0003075_altered_response_to | 1.68308148 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.66677399 |
| 31 | MP0001873_stomach_inflammation | 1.65489998 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.54253966 |
| 33 | MP0005451_abnormal_body_composition | 1.53590162 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.52938544 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.52050904 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.47004841 |
| 37 | MP0005381_digestive/alimentary_phenotyp | 1.45667532 |
| 38 | MP0002254_reproductive_system_inflammat | 1.38830144 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.37784250 |
| 40 | MP0004947_skin_inflammation | 1.36897446 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.34883045 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.34740408 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.34511895 |
| 44 | * MP0000703_abnormal_thymus_morphology | 1.34036924 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.33886666 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.33236895 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.31658774 |
| 48 | MP0002796_impaired_skin_barrier | 1.28430723 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.25617020 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.25566298 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.24133525 |
| 52 | MP0008004_abnormal_stomach_pH | 1.23292671 |
| 53 | MP0003448_altered_tumor_morphology | 1.23256783 |
| 54 | MP0009785_altered_susceptibility_to | 1.17540046 |
| 55 | MP0005310_abnormal_salivary_gland | 1.17523570 |
| 56 | MP0005501_abnormal_skin_physiology | 1.16464749 |
| 57 | MP0000343_altered_response_to | 1.16155562 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.14447799 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.13244330 |
| 60 | * MP0003252_abnormal_bile_duct | 1.11313404 |
| 61 | MP0001800_abnormal_humoral_immune | 1.10945316 |
| 62 | MP0005166_decreased_susceptibility_to | 1.07647797 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 1.06775087 |
| 64 | MP0009763_increased_sensitivity_to | 1.06185902 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.03427420 |
| 66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02612865 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.02223847 |
| 68 | MP0004043_abnormal_pH_regulation | 1.01495911 |
| 69 | MP0001849_ear_inflammation | 1.00941389 |
| 70 | MP0003763_abnormal_thymus_physiology | 0.99102558 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.97563976 |
| 72 | MP0008007_abnormal_cellular_replicative | 0.97332910 |
| 73 | MP0002398_abnormal_bone_marrow | 0.96897006 |
| 74 | MP0002166_altered_tumor_susceptibility | 0.96892329 |
| 75 | MP0002420_abnormal_adaptive_immunity | 0.96642272 |
| 76 | MP0001819_abnormal_immune_cell | 0.96183816 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.96097536 |
| 78 | MP0005448_abnormal_energy_balance | 0.95569883 |
| 79 | MP0003724_increased_susceptibility_to | 0.95565078 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.95534216 |
| 81 | MP0005025_abnormal_response_to | 0.94611881 |
| 82 | MP0000467_abnormal_esophagus_morphology | 0.92571758 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.90507686 |
| 84 | MP0005023_abnormal_wound_healing | 0.90332784 |
| 85 | MP0002933_joint_inflammation | 0.90298473 |
| 86 | MP0003718_maternal_effect | 0.89706310 |
| 87 | * MP0005266_abnormal_metabolism | 0.88906032 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.88441151 |
| 89 | MP0000604_amyloidosis | 0.88273990 |
| 90 | MP0002429_abnormal_blood_cell | 0.87634950 |
| 91 | MP0002723_abnormal_immune_serum | 0.87471888 |
| 92 | MP0000249_abnormal_blood_vessel | 0.85496202 |
| 93 | MP0003436_decreased_susceptibility_to | 0.85349524 |
| 94 | MP0001664_abnormal_digestion | 0.85276809 |
| 95 | MP0001764_abnormal_homeostasis | 0.85261904 |
| 96 | MP0000716_abnormal_immune_system | 0.84975529 |
| 97 | MP0003646_muscle_fatigue | 0.84783413 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.84520595 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.84419284 |
| 100 | * MP0000609_abnormal_liver_physiology | 0.84228387 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.84173036 |
| 102 | MP0001191_abnormal_skin_condition | 0.84137054 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.84011856 |
| 104 | MP0003878_abnormal_ear_physiology | 0.83492080 |
| 105 | MP0005377_hearing/vestibular/ear_phenot | 0.83492080 |
| 106 | MP0010307_abnormal_tumor_latency | 0.83303725 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.83019005 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.81134290 |
| 109 | MP0000858_altered_metastatic_potential | 0.79085675 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.77914705 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.77401172 |
| 112 | * MP0002722_abnormal_immune_system | 0.76673745 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.75496573 |
| 114 | MP0005165_increased_susceptibility_to | 0.75058008 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.75000278 |
| 116 | MP0005671_abnormal_response_to | 0.74617890 |
| 117 | MP0005000_abnormal_immune_tolerance | 0.73404268 |
| 118 | MP0003077_abnormal_cell_cycle | 0.72964232 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.71544603 |
| 120 | MP0002419_abnormal_innate_immunity | 0.70035485 |
| 121 | MP0002095_abnormal_skin_pigmentation | 0.69607735 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.69455500 |
| 123 | MP0001730_embryonic_growth_arrest | 0.69065966 |
| 124 | MP0003186_abnormal_redox_activity | 0.68627159 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.68618677 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.68307699 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.68307699 |
| 128 | MP0005390_skeleton_phenotype | 0.68073096 |
| 129 | MP0008469_abnormal_protein_level | 0.66848598 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.66721258 |
| 131 | MP0002132_abnormal_respiratory_system | 0.66491333 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.66451870 |
| 133 | MP0002006_tumorigenesis | 0.66402100 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.65980238 |
| 135 | * MP0002405_respiratory_system_inflammati | 0.64188543 |
| 136 | MP0000685_abnormal_immune_system | 0.62473590 |
| 137 | MP0003111_abnormal_nucleus_morphology | 0.61483550 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.60167855 |
| 139 | MP0004381_abnormal_hair_follicle | 0.57572941 |
| 140 | MP0005535_abnormal_body_temperature | 0.55254497 |
| 141 | * MP0000313_abnormal_cell_death | 0.54162286 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.51820441 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.49149899 |
| 144 | MP0002163_abnormal_gland_morphology | 0.48727947 |
| 145 | MP0003795_abnormal_bone_structure | 0.47870611 |
| 146 | MP0005647_abnormal_sex_gland | 0.47213843 |
| 147 | MP0001542_abnormal_bone_strength | 0.45841867 |
| 148 | MP0005164_abnormal_response_to | 0.45477593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 6.24914224 |
| 2 | Acanthocytosis (HP:0001927) | 6.04686161 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.02090914 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.90056231 |
| 5 | Hydroxyprolinuria (HP:0003080) | 4.83577908 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 4.83577908 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.74634112 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.61118703 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.61118703 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.61118703 |
| 11 | Stomatitis (HP:0010280) | 4.54249273 |
| 12 | Hypoproteinemia (HP:0003075) | 4.48568813 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.27512681 |
| 14 | Oral leukoplakia (HP:0002745) | 4.20104090 |
| 15 | Malnutrition (HP:0004395) | 4.05707822 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 4.02068211 |
| 17 | Chronic diarrhea (HP:0002028) | 3.94627079 |
| 18 | Increased IgM level (HP:0003496) | 3.94178075 |
| 19 | Poikilocytosis (HP:0004447) | 3.92542577 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.84007282 |
| 21 | Meningitis (HP:0001287) | 3.83594290 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.78165959 |
| 23 | Increased mean platelet volume (HP:0011877) | 3.72471929 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.62221625 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.59404012 |
| 26 | Abnormal platelet volume (HP:0011876) | 3.58686628 |
| 27 | Orchitis (HP:0100796) | 3.45844159 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.44856634 |
| 29 | IgG deficiency (HP:0004315) | 3.44658543 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.43554347 |
| 31 | Optic neuritis (HP:0100653) | 3.43554347 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.43072135 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.34622411 |
| 34 | Impaired platelet aggregation (HP:0003540) | 3.22643723 |
| 35 | Abnormal platelet function (HP:0011869) | 3.22643723 |
| 36 | Polycythemia (HP:0001901) | 3.22060197 |
| 37 | * Combined immunodeficiency (HP:0005387) | 3.21689176 |
| 38 | T lymphocytopenia (HP:0005403) | 3.16915342 |
| 39 | * Recurrent fungal infections (HP:0002841) | 3.16241697 |
| 40 | * Severe combined immunodeficiency (HP:0004430) | 3.14492671 |
| 41 | Pigmentary retinal degeneration (HP:0001146) | 3.12272572 |
| 42 | Obstructive lung disease (HP:0006536) | 3.08149896 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 3.08149896 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 3.07617486 |
| 45 | Loss of speech (HP:0002371) | 3.07538653 |
| 46 | Nonimmune hydrops fetalis (HP:0001790) | 3.01159479 |
| 47 | Abnormality of T cell number (HP:0011839) | 3.01021297 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 3.00449489 |
| 49 | Vasculitis (HP:0002633) | 2.90730476 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90084605 |
| 51 | Thrombocytosis (HP:0001894) | 2.88986381 |
| 52 | Abnormal glucose tolerance (HP:0001952) | 2.83079234 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.80070196 |
| 54 | Myopathic facies (HP:0002058) | 2.80056954 |
| 55 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79043630 |
| 56 | Fat malabsorption (HP:0002630) | 2.78714310 |
| 57 | Colitis (HP:0002583) | 2.78363943 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.77107190 |
| 59 | * Autoimmune thrombocytopenia (HP:0001973) | 2.75780047 |
| 60 | Reticulocytosis (HP:0001923) | 2.75347918 |
| 61 | Gastrointestinal dysmotility (HP:0002579) | 2.74367469 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.68174997 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.67211719 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.67036745 |
| 65 | Pustule (HP:0200039) | 2.65965180 |
| 66 | Abnormality of urine glucose concentration (HP:0011016) | 2.65751061 |
| 67 | Glycosuria (HP:0003076) | 2.65751061 |
| 68 | Acute lymphatic leukemia (HP:0006721) | 2.64358437 |
| 69 | Recurrent pneumonia (HP:0006532) | 2.58783287 |
| 70 | Abdominal distention (HP:0003270) | 2.56575052 |
| 71 | IgM deficiency (HP:0002850) | 2.50364281 |
| 72 | Dehydration (HP:0001944) | 2.48786741 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.48458271 |
| 74 | Recurrent skin infections (HP:0001581) | 2.47442981 |
| 75 | * Autoimmune hemolytic anemia (HP:0001890) | 2.47291544 |
| 76 | Facial diplegia (HP:0001349) | 2.47044689 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46278536 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.46196882 |
| 79 | * Hypergammaglobulinemia (HP:0010702) | 2.45048730 |
| 80 | Petechiae (HP:0000967) | 2.44992477 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.44965483 |
| 82 | Abnormality of reticulocytes (HP:0004312) | 2.40278776 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.39784967 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38593187 |
| 85 | Hyperglycinuria (HP:0003108) | 2.37292580 |
| 86 | Increased serum ferritin (HP:0003281) | 2.37025109 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.35313827 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.35031480 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.34787211 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.34787211 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31222496 |
| 92 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29888935 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.27802936 |
| 94 | Woolly hair (HP:0002224) | 2.27604937 |
| 95 | * Sepsis (HP:0100806) | 2.27168764 |
| 96 | Urticaria (HP:0001025) | 2.25097438 |
| 97 | Disinhibition (HP:0000734) | 2.23275466 |
| 98 | * Granulocytopenia (HP:0001913) | 2.22653205 |
| 99 | Ragged-red muscle fibers (HP:0003200) | 2.22143052 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.21599637 |
| 101 | Mutism (HP:0002300) | 2.19420582 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.18970488 |
| 103 | Abnormality of the gastric mucosa (HP:0004295) | 2.18750649 |
| 104 | Chronic otitis media (HP:0000389) | 2.18370906 |
| 105 | Prostate neoplasm (HP:0100787) | 2.17983999 |
| 106 | Hypertensive crisis (HP:0100735) | 2.17805076 |
| 107 | Purpura (HP:0000979) | 2.17313844 |
| 108 | Progressive neurologic deterioration (HP:0002344) | 2.15449772 |
| 109 | Encephalitis (HP:0002383) | 2.14845692 |
| 110 | Gangrene (HP:0100758) | 2.11056986 |
| 111 | Microretrognathia (HP:0000308) | 2.10949448 |
| 112 | * Leukocytosis (HP:0001974) | 2.10451099 |
| 113 | * Lymphoma (HP:0002665) | 2.09866577 |
| 114 | * Recurrent viral infections (HP:0004429) | 2.09481882 |
| 115 | Widely patent fontanelles and sutures (HP:0004492) | 2.09298385 |
| 116 | Cheilitis (HP:0100825) | 2.08940705 |
| 117 | Hypoplasia of the thymus (HP:0000778) | 2.08602687 |
| 118 | Hypercholesterolemia (HP:0003124) | 2.06535953 |
| 119 | Megaloblastic anemia (HP:0001889) | 2.06041566 |
| 120 | Pili torti (HP:0003777) | 2.05147122 |
| 121 | Nephrolithiasis (HP:0000787) | 2.04180024 |
| 122 | Polygenic inheritance (HP:0010982) | 2.02672011 |
| 123 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.02601293 |
| 124 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00104673 |
| 125 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00104673 |
| 126 | Amaurosis fugax (HP:0100576) | 1.99758042 |
| 127 | Calcaneovalgus deformity (HP:0001848) | 1.98999656 |
| 128 | Basal ganglia calcification (HP:0002135) | 1.97862050 |
| 129 | Papilloma (HP:0012740) | 1.97236777 |
| 130 | Verrucae (HP:0200043) | 1.97236777 |
| 131 | Multiple enchondromatosis (HP:0005701) | 1.96976515 |
| 132 | * Lymphopenia (HP:0001888) | 1.96629915 |
| 133 | Hemoptysis (HP:0002105) | 1.96606654 |
| 134 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94777665 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.94777665 |
| 136 | Nasal polyposis (HP:0100582) | 1.94491796 |
| 137 | Abnormality of lateral ventricle (HP:0030047) | 1.94459659 |
| 138 | Wide cranial sutures (HP:0010537) | 1.94283255 |
| 139 | Osteomyelitis (HP:0002754) | 1.93446852 |
| 140 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92891855 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.92457240 |
| 142 | Rectal prolapse (HP:0002035) | 1.92128207 |
| 143 | Recurrent bronchitis (HP:0002837) | 1.91687320 |
| 144 | Xanthomatosis (HP:0000991) | 1.91354440 |
| 145 | Hypoalbuminemia (HP:0003073) | 1.90117852 |
| 146 | Abnormal albumin level (HP:0012116) | 1.90117852 |
| 147 | Gastrointestinal stroma tumor (HP:0100723) | 1.89030761 |
| 148 | Abnormality of T cells (HP:0002843) | 1.87134281 |
| 149 | Micronodular cirrhosis (HP:0001413) | 1.85584365 |
| 150 | Tongue fasciculations (HP:0001308) | 1.83171699 |
| 151 | Muscle fibrillation (HP:0010546) | 1.82825639 |
| 152 | Abnormality of the calcaneus (HP:0008364) | 1.82806543 |
| 153 | IgA deficiency (HP:0002720) | 1.82790217 |
| 154 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81647724 |
| 155 | Skin rash (HP:0000988) | 1.80845065 |
| 156 | Breast hypoplasia (HP:0003187) | 1.79484181 |
| 157 | Fatigue (HP:0012378) | 1.79044171 |
| 158 | Myositis (HP:0100614) | 1.78541592 |
| 159 | Increased connective tissue (HP:0009025) | 1.78489504 |
| 160 | Abnormal biliary tract morphology (HP:0012440) | 1.77936015 |
| 161 | Reticulocytopenia (HP:0001896) | 1.77933635 |
| 162 | Gingivitis (HP:0000230) | 1.77569884 |
| 163 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.76902229 |
| 164 | * B lymphocytopenia (HP:0010976) | 1.75344844 |
| 165 | * Abnormality of B cell number (HP:0010975) | 1.75344844 |
| 166 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74446332 |
| 167 | Villous atrophy (HP:0011473) | 1.74446332 |
| 168 | Palpitations (HP:0001962) | 1.74299742 |
| 169 | Nausea (HP:0002018) | 1.74260507 |
| 170 | Spontaneous hematomas (HP:0007420) | 1.74075121 |
| 171 | Aplastic anemia (HP:0001915) | 1.71709477 |
| 172 | Cellulitis (HP:0100658) | 1.71415778 |
| 173 | Abnormality of the fingertips (HP:0001211) | 1.71158432 |
| 174 | Abnormality of purine metabolism (HP:0004352) | 1.70476078 |
| 175 | Macrocytic anemia (HP:0001972) | 1.69592308 |
| 176 | Alopecia of scalp (HP:0002293) | 1.68198418 |
| 177 | * Abnormality of eosinophils (HP:0001879) | 1.65862226 |
| 178 | Ulnar deviation of the wrist (HP:0003049) | 1.64973401 |
| 179 | Abnormality of nucleobase metabolism (HP:0010932) | 1.64729263 |
| 180 | Deformed tarsal bones (HP:0008119) | 1.64473168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.36523037 |
| 2 | MST4 | 4.06998835 |
| 3 | IRAK3 | 3.28857049 |
| 4 | GRK6 | 2.90193819 |
| 5 | MAP4K1 | 2.58482188 |
| 6 | VRK2 | 2.56468751 |
| 7 | ERN1 | 2.51039836 |
| 8 | MAP3K10 | 2.47118831 |
| 9 | TESK2 | 2.24982489 |
| 10 | TAOK2 | 2.22147271 |
| 11 | PRKG2 | 2.15497349 |
| 12 | STK10 | 2.14869521 |
| 13 | GRK7 | 2.14804870 |
| 14 | MST1R | 2.11528667 |
| 15 | LMTK2 | 2.02514708 |
| 16 | EPHA2 | 1.89164563 |
| 17 | IKBKB | 1.89014752 |
| 18 | AKT3 | 1.88268666 |
| 19 | RIPK4 | 1.80326854 |
| 20 | BCKDK | 1.79315074 |
| 21 | NME1 | 1.76184121 |
| 22 | PIM2 | 1.75570006 |
| 23 | PTK6 | 1.73842817 |
| 24 | TXK | 1.72119203 |
| 25 | SCYL2 | 1.70271257 |
| 26 | PDK2 | 1.66212143 |
| 27 | RIPK1 | 1.61206181 |
| 28 | BRSK2 | 1.58368427 |
| 29 | PRPF4B | 1.56431130 |
| 30 | TIE1 | 1.55119932 |
| 31 | TBK1 | 1.50850045 |
| 32 | PAK4 | 1.50374493 |
| 33 | BMPR2 | 1.43932194 |
| 34 | TEC | 1.42253625 |
| 35 | KDR | 1.40058385 |
| 36 | CDC7 | 1.39325935 |
| 37 | NUAK1 | 1.38334228 |
| 38 | TGFBR1 | 1.37002505 |
| 39 | MAP2K2 | 1.34984614 |
| 40 | TESK1 | 1.33891683 |
| 41 | LRRK2 | 1.30500609 |
| 42 | TGFBR2 | 1.30059467 |
| 43 | MAP3K11 | 1.29264366 |
| 44 | KIT | 1.26975788 |
| 45 | ARAF | 1.26800651 |
| 46 | WEE1 | 1.23745820 |
| 47 | MAP3K13 | 1.21813189 |
| 48 | MAP3K8 | 1.21181491 |
| 49 | BUB1 | 1.20029826 |
| 50 | MOS | 1.19421429 |
| 51 | NME2 | 1.18417162 |
| 52 | FES | 1.15780715 |
| 53 | PASK | 1.14400034 |
| 54 | EEF2K | 1.14249577 |
| 55 | TAOK3 | 1.13050344 |
| 56 | CSF1R | 1.12474429 |
| 57 | BTK | 1.07806617 |
| 58 | TTK | 1.06667528 |
| 59 | MATK | 1.05411357 |
| 60 | EIF2AK1 | 1.04835525 |
| 61 | ADRBK2 | 1.03841091 |
| 62 | FLT3 | 1.00909607 |
| 63 | RPS6KB2 | 1.00784753 |
| 64 | PKN2 | 0.98974185 |
| 65 | PRKCI | 0.93939609 |
| 66 | TTN | 0.93722521 |
| 67 | RPS6KA4 | 0.93124958 |
| 68 | VRK1 | 0.92159732 |
| 69 | DDR2 | 0.92005876 |
| 70 | SMG1 | 0.91049829 |
| 71 | ABL2 | 0.90411032 |
| 72 | CLK1 | 0.89758923 |
| 73 | CDK6 | 0.87609490 |
| 74 | IRAK4 | 0.87592992 |
| 75 | TYK2 | 0.86229856 |
| 76 | MAP2K3 | 0.84772243 |
| 77 | ACVR1B | 0.82615320 |
| 78 | AURKB | 0.81087342 |
| 79 | MAP3K6 | 0.79867052 |
| 80 | PIM1 | 0.78750324 |
| 81 | DAPK1 | 0.78694621 |
| 82 | EIF2AK3 | 0.76984636 |
| 83 | MAPKAPK3 | 0.76615882 |
| 84 | PIK3CG | 0.76520972 |
| 85 | BLK | 0.75417333 |
| 86 | HCK | 0.74368696 |
| 87 | FGR | 0.74247893 |
| 88 | MAP2K6 | 0.72331528 |
| 89 | NEK2 | 0.71738097 |
| 90 | TNK2 | 0.71284861 |
| 91 | TAOK1 | 0.70465243 |
| 92 | IKBKE | 0.69555933 |
| 93 | MAP3K5 | 0.66958646 |
| 94 | MAP3K3 | 0.66823802 |
| 95 | ITK | 0.66746812 |
| 96 | MAPK11 | 0.66431591 |
| 97 | CDK7 | 0.64251783 |
| 98 | SYK | 0.64063195 |
| 99 | ZAP70 | 0.63147714 |
| 100 | MAP3K7 | 0.62449696 |
| 101 | CSK | 0.60861741 |
| 102 | MAP3K1 | 0.59023803 |
| 103 | NEK1 | 0.57658733 |
| 104 | BRSK1 | 0.53959099 |
| 105 | TLK1 | 0.53014008 |
| 106 | IRAK2 | 0.52548218 |
| 107 | RPS6KA5 | 0.51808105 |
| 108 | EIF2AK2 | 0.51672337 |
| 109 | JAK3 | 0.51557154 |
| 110 | AKT2 | 0.51526210 |
| 111 | HIPK2 | 0.50950097 |
| 112 | MAPKAPK5 | 0.49781679 |
| 113 | MAPKAPK2 | 0.49497442 |
| 114 | DAPK3 | 0.48921506 |
| 115 | NEK9 | 0.48524920 |
| 116 | BRAF | 0.46491609 |
| 117 | EPHB2 | 0.46348179 |
| 118 | CDK12 | 0.46343356 |
| 119 | MAPK4 | 0.45617179 |
| 120 | PBK | 0.45586376 |
| 121 | IRAK1 | 0.44750148 |
| 122 | JAK1 | 0.44056645 |
| 123 | PRKCQ | 0.43728623 |
| 124 | LCK | 0.43556221 |
| 125 | CDC42BPA | 0.43335086 |
| 126 | ERBB2 | 0.43270587 |
| 127 | TAF1 | 0.43094847 |
| 128 | ATR | 0.43083987 |
| 129 | PLK1 | 0.42798289 |
| 130 | JAK2 | 0.42410079 |
| 131 | DYRK3 | 0.40871280 |
| 132 | ZAK | 0.40278338 |
| 133 | PLK4 | 0.38425023 |
| 134 | CCNB1 | 0.37916359 |
| 135 | FER | 0.37507345 |
| 136 | LYN | 0.36895079 |
| 137 | MAP3K2 | 0.36622552 |
| 138 | CDK4 | 0.36432662 |
| 139 | MAP3K14 | 0.35375916 |
| 140 | CHEK2 | 0.34695820 |
| 141 | NLK | 0.34483637 |
| 142 | STK4 | 0.34324215 |
| 143 | CDK9 | 0.33431608 |
| 144 | TRIB3 | 0.32997986 |
| 145 | BMX | 0.32966490 |
| 146 | CHUK | 0.32540980 |
| 147 | MARK3 | 0.29895680 |
| 148 | CSNK1G3 | 0.29675871 |
| 149 | AURKA | 0.28283428 |
| 150 | RPS6KL1 | 0.25749620 |
| 151 | RPS6KC1 | 0.25749620 |
| 152 | CDK14 | 0.24858917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.36369770 |
| 2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.39072699 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.25596148 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.09236196 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.99686558 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.35593848 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.27637518 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.07098299 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.05023139 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.02463105 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.96710067 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.79287264 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.52516293 |
| 14 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.38275777 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.23211785 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.22912848 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.22789315 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.18861627 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07461524 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03979483 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 2.03399433 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02434563 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.74053907 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.73679555 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68869205 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67185734 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.61737698 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.57585388 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.53839860 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52335364 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51008560 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49723698 |
| 33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.45309777 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43450590 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.36971534 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36698072 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34952820 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31430361 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.28928614 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.26468306 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.22420571 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21746332 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19943233 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19172506 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.18768247 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18065190 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14272355 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13503580 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11658500 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06248391 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05933757 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04155768 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04079669 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02231341 |
| 55 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97538978 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96932679 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96907275 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95916738 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91917844 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91380135 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87660094 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85933151 |
| 63 | Ribosome_Homo sapiens_hsa03010 | 0.84929028 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84642153 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84453510 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.81327733 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80955740 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77318218 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76906234 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76559723 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76545828 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76099116 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75168132 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73786529 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72819830 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.71232206 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71148346 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.68981104 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67208422 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66084845 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63919796 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.62346214 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62202155 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.61525511 |
| 85 | * Purine metabolism_Homo sapiens_hsa00230 | 0.60069712 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59730744 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59129205 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56259250 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55270102 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.54620869 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54065613 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.52814541 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50844657 |
| 94 | Cell cycle_Homo sapiens_hsa04110 | 0.49452991 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47209062 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46316808 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45775988 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45120294 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44743265 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44703022 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44000708 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42184524 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41644218 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.41321787 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40939010 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40787610 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.36651561 |
| 108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36631400 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.35959311 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35437497 |
| 111 | RNA polymerase_Homo sapiens_hsa03020 | 0.35391030 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.35197675 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34005522 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.33506952 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33202585 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32317353 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.31990592 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31131760 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30802524 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30494537 |
| 121 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30172631 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30045256 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29328007 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28596090 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27875409 |
| 126 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27508422 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27508083 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.26817861 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25475908 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24330552 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.23958800 |
| 132 | Spliceosome_Homo sapiens_hsa03040 | 0.23638872 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22225198 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.21063356 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.20756515 |
| 136 | Proteasome_Homo sapiens_hsa03050 | 0.19998206 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.19615334 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.19342664 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19190370 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.18672197 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.18412067 |
| 142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18004627 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17622231 |
| 144 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.17112626 |
| 145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15494385 |
| 146 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14199630 |
| 147 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12700051 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.09511292 |
| 149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09414971 |
| 150 | Alzheimers disease_Homo sapiens_hsa05010 | 0.08607532 |
| 151 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07468046 |

